US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.608
  • -0.018-2.85%
Trading Mar 18 11:51 ET
51.66MMarket Cap-0.33P/E (TTM)

Century Therapeutics Key Stats

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 18, 2025

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data